Scholarly Index
Mallikarjuna Rettiganti
Eli Lilly (United States); 1,782 total citations; 143 total publications; best world rank #380
Eli Lilly (United States)
1,782Total citations
143Total publications
22H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| Migraine and Headache Studies | 2021-2025 | 889 | US 212 | 75.08 |
| Trigeminal Neuralgia and Treatments | 2021-2025 | 601 | US 142 | 68.54 |
| Sympathectomy and Hyperhidrosis Treatments | 2021-2025 | 380 | US 93 | 55.80 |